Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

80%

Ph phase_3

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 3Large-scale testing

1(20.0%)

N/ANon-phased studies

4(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Other(3)

Detailed Status

unknown3

Completed2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (20.0%)

N/A4 (80.0%)

Trials by Status

completed240%

unknown360%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE)

NCT04375774

unknownphase_3

Supreme-LMA for Neonatal Resuscitation: a Prospective, Randomized Single-center Study

NCT01963936

Clinical Trials (5)

Showing 5 of 5 trials

NCT03554863Not Applicable

High Flow Oxygen in Patients Undergoing Surgery Under General Anesthesia

Completed

NCT05532033Not Applicable

High Flow Nasal Cannula and Diaphragmatic Function

Completed

NCT04387175Not Applicable

Intraoral Device vs Facial Mask for Class III Treatment

Unknown

NCT04375774Not Applicable

Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE)

Unknown

NCT01963936Phase 3

Supreme-LMA for Neonatal Resuscitation: a Prospective, Randomized Single-center Study

Unknown

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5